(2024)131 demonstrated a synergistic association of amyloid-β and tau pathology with cortical neurophysiology in AD, highlighting increases in delta-theta power (2–7Hz) and reduction of power in alpha band (8–12Hz) and beta band (15–29Hz) in patients with greater levels of amyloid and tau burden. This evidence concerns the gene MAPT and Alzheimer disease.